Our peak young man-Liu Chen Qian
Release time:
2023-05-04
Liu Chen Qian
Age: 24
Position: Huang Ping Jianfeng Marketing Department
Entry Time: April 2020
First Job, Be Good!
Among the salesmen in Huang Ping's peak, Liu Chen Qian is the youngest, born in 1998, and his family is Lanxi, known as "Little Shanghai. In April 2020, the first wave of the new crown epidemic has not yet eased, on the Internet to see Huang Ping peak recruitment information he submitted a resume, a few days to receive a trial notice.
rushed to Guizhou to welcome his first job in his life. Before he entered the factory, Liu Chen Qian was poured cold water. When I got off the train in Kaili, Yang Zhendong, vice president of peak sales in Huang Ping, was working in Kaili. By the way, I connected him and entered the mountain as soon as I got out of the city. The car jolted on the winding and potholed mountain road. Liu Chen Qian blurted out, "This road is too bad." Yang Zhendong teased him: "If you regret it, it is still too late to go back."
Regret No Regret No Regret No One Can Know, Of Course, Liu Chen Qian Has Been in Huang Ping Ever Since. At that time, Huang Ping Jianfeng had not yet been put into production, and the marketing department had not been in operation for a long time. The vast majority of them were "fresh people" who had never had any experience in cement sales. When conducting market research in groups, he often crustily skin of head and took the initiative to strike up a conversation with local customers. Even if it was a "awkward chat", he would go to get acquainted with them first. Before long, he left the impression of "diligent" and "bold" on his leaders and colleagues.
has been in the Huang Ping branch for more than a year. Although Liu Chen Qian's sales performance is not outstanding, he has made obvious progress from not knowing what to say at the regular department meeting to being able to analyze the customer and market in an orderly way. Moreover, he also has the ability to resist pressure beyond most of his peers, the criticism of leaders, the complaints of customers, and the complaints of cement truck drivers. Soon, many customers fell in love with this white and clean young man from other places. Some cement truck drivers even queued up to pick up the goods in the factory in the middle of the night and called him to have a snack together. As for the differences in language and food life, it is certainly not a problem.
2022 , the leader "threw" Liu Chen Qian to Yu Qing branch to open up a blank market. "Stocking" in the "one-person branch" means that most things can only rely on oneself. During that time, Liu Chenqian visited cement users during the day and took time to read books and study at night to supplement his marketing knowledge and social experience lessons. This is his requirement for himself and the requirement of the marketing department for all marketers. Everything comes to him who waits. Over the past few months, Yu Qing's branch has gradually improved.
This year, Liu Chenqian was transferred back to the Huang Ping branch. Although it was only a year later, the market situation has changed, the competition situation has changed, and the customer relationship has changed, which has also put him under a lot of pressure. As an "old salesman" who has worked for three years, Liu Chenqian, like Huang Ping Jianfeng, still has a long way to go in the future. He is also working side by side with his colleagues. (Reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31